Nicholas C.P. Cross

Salisbury District Hospital — United Kingdom

Medicine · Health Sciences

100h-index44.6kcitations644works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(309), Eosinophilic Disorders and Syndromes(237), Myeloproliferative Neoplasms: Diagnosis and Treatment(225), Acute Myeloid Leukemia Research(166), Chronic Lymphocytic Leukemia Research(125)

Publications642 total

Investigation and management of thrombocytosis without <scp> <i>JAK2</i> </scp> , <scp> <i>CALR</i> </scp> or <scp> <i>MPL</i> </scp> mutations: A British Society for Haematology Guideline
British Journal of Haematology·2025Open Access
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes
Leukemia·2025Open Access
BCR::ABL1/GUSB halving times predict molecular response to asciminib at 18 months
Blood·2025Open Access
Evaluating reverse transcriptase efficiency in CML: Consequences for deep molecular response classification and treatment-free remission decisions
Blood·2025
Nanopore sequencing to detect BCR::ABL1 and associated genomic rearrangements in CML
Blood·2025Open Access
Safety and Pharmacodynamics of SGB-9768, an siRNA Targeting Complement C3 in Healthy Volunteers
Journal of the American Society of Nephrology·2025
Genome-wide analysis defines genetic determinants of MPN subtypes and identifies a sex-specific association at <i>CDH22</i> / <i>CD40</i>
Blood·2025· 1 citedOpen Access
EXABS-144-CML: Predicting Outcomes in Chronic Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2025
Clinical, morphological and genetic characteristics of patients with concurrent presence of JAK2 V617F and BCR::ABL1
Scientific Reports·2025Open Access
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Leukemia·2025· 43 citedOpen Access
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&amp;G Committee and the CMWP of the EBMT
Blood·2025· 4 citedOpen Access
The <i>JAK2</i> 46/1 haplotype influences PD-L1 expression
Blood·2025· 1 citedOpen Access
Optimizing Molecular Diagnosis of Systemic Mastocytosis in the Era of KIT Tyrosine Kinase Inhibitors: Results of a Survey and of a Nationwide Proficiency Control Round of KIT D816V Mutation Testing Promoted By the RIMA (Rete Italiana MAstocitosi) Association
Blood·2024· 1 citedOpen Access
How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions
Blood·2024· 12 cited
Recommendations from the AML molecular MRD expert advisory board
Leukemia·2024· 4 citedOpen Access
Capture‐based targeted sequencing using a T‐cell control in myeloid malignancies and idiopathic cytopenias
British Journal of Haematology·2024Open Access
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis
Cancers·2024· 3 citedOpen Access
Referee report. For: Impact of CYP3A4 rs2242480 polymorphisms on Imatinib HPLC determined trough concentration and response in Chronic Myeloid Leukaemia in Pakistani patients [version 1; peer review: 1 approved with reservations, 1 not approved]
Faculty of 1000 Research Ltd·2024Open Access
The management of myelofibrosis: A British Society for Haematology Guideline
British Journal of Haematology·2023· 13 citedOpen Access
Bimékizumab : efficacité à 3 ans dans les zones à fort impact dans le psoriasis en plaques modéré à sévère : résultats regroupés de cinq essais de phase 3/3b
Annales de Dermatologie et de Vénéréologie - FMC·2023
page 1 of 33Next →

Frequent Co-authors

Andreas Hochhaus(13), Andreas Reiter(12), Andrew Chase(10), John M. Goldman(8), Giuseppe Saglio(7), Torsten Haferlach(6), Amy V. Jones(6), Ayalew Tefferi(6), Thomas Ernst(6), Katerina Zoi(6), Jane F. Apperley(5), Elli Papaemmanuil(5), Jacqueline Boultwood(5), Mario Cazzola(5), Peter J. Campbell(5), E. Joanna Baxter(5), Joannah Score(5), Rüdiger Hehlmann(5), Animesh Pardanani(5), Luca Malcovati(4)